NP Bioinnovation A/S: Financial statements 2026
CVR: 41598263
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
NP Bioinnovation A/S (CVR 41598263) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 4,853,562 and a net result of DKK -5,521,565 compared with DKK -60,069 the year before. Equity in the 2026 report amounted to DKK -5,353,675. The company had 11 employees in the financial year.
- Gross Profit
- DKK 4,853,562
- Profit/Loss
- DKK -5,521,565
- Equity
- DKK -5,353,675
- Total Assets
- DKK 8,481,866
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 4.9M | -5.5M | -5.4M | 11 |
| 2025 | - | -32K | -60K | 168K | 0 |
| 2024 | - | -59K | -80K | 228K | 0 |
Official annual report
Find more companies like NP Bioinnovation A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Contact info changed: new email: [email protected] (April 22, 2026).
Address changed to Vandtårnsvej 62A 1. b 62, 1 b, 2860 Søborg (February 2, 2026).
Contact info changed: new email: [email protected] (February 2, 2026).
About NP Bioinnovation A/S
NP Bioinnovation A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named NP Communications A/S and Managementselskabet af 12.08.2020 A/S. The management consists of Christian Torben Hill-Madsen. The board consists of Peter Severin Bach (chair), Allan Traugott Wehnert and Henrik Rouf. The company is owned by Nordicus Partners Corporation. The company has 12 employees (2026). In 2026, the company reported a gross profit of DKK 4,853,562 and a net result of DKK -5,521,565 compared with DKK -60,069 the year before. Equity in the 2026 report amounted to DKK -5,353,675.